User menu

Neurohormonal and hemodynamic effects of ibopamine.

Bibliographic reference Pouleur, H.. Neurohormonal and hemodynamic effects of ibopamine.. In: Clinical cardiology, Vol. 18, no. 3 Suppl I, p. I17-21 (1995)
Permanent URL
  1. Rajfer, J Am Coll Cardiol, 10, 1286 (1987)
  2. Rajfer S. I., Rossen J. D., Douglas F. L., Goldberg L. I., Karrison T., Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels, 10.1161/01.cir.73.4.740
  3. van Veldhuisen, Am J Cardiol, 71, 992 (1993)
  4. Rousseau, Am J Cardiol, 73, 488 (1994)
  5. Halabi A, Kirch W: The effects of ibopamine on cardiac and renal function in patients with congestive heart failure and different degrees of renal function. Br J Clin Pharmacol, Proceedings of the BPS, 35/5, 539 (1993).
  6. Pouleur H., Raigoso J., Rousseau M. F., Dopaminergic drugs in the management of chronic heart failure, 10.1093/eurheartj/12.suppl_c.29
  7. Rousseau, J Cardiovasc Pharmacol, 19, 155 (1992)
  8. Parker, Intern J Cardiol, 40, 221 (1993)
  9. Azzollini, Cardiology, 77, 89 (1990)
  10. Condorelli M., Bonaduce A., Montemurro A., Mattioli G., Cappello C., Caponnetto S., Terrachini V., Canale C., Varricchio M., Cacciapuoti F., Colonna L., Luca I. De, Paciaroni E., Gigli L., Guiducci U., Brandi L., Gavazzi A., Montemartini C., Cucchini F., The Long-Term Efficacy of Ibopamine in Treating Patients with Severe Heart Failure : A Multicenter Investigation, 10.1097/00005344-198900148-00009
  11. Kayanakis, Am J Noninvas Cardial, 5, 31 (1991)
  12. Van Veldhuisen, J Am Coll Cardiol, 22, 1564 (1993)
  13. Caratge, Clinical Report, MP12Si (1987)